Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CHRNB4 Antikörper (C-Term)

CHRNB4 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB42408 unconjugated
Produktnummer ABIN1881200
  • Target Alle CHRNB4 Antikörper anzeigen
    CHRNB4 (Cholinergic Receptor, Nicotinic, beta 4 (Neuronal) (CHRNB4))
    Bindungsspezifität
    • 12
    • 7
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 422-450, C-Term
    Reaktivität
    • 27
    • 10
    • 8
    Human
    Wirt
    • 25
    • 2
    • 1
    Kaninchen
    Klonalität
    • 27
    • 1
    Polyklonal
    Konjugat
    • 11
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CHRNB4 Antikörper ist unkonjugiert
    Applikation
    • 20
    • 18
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Aufreinigung
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This CHRNB4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 422-450 amino acids from the C-terminal region of human CHRNB4.
    Klon
    RB42408
    Isotyp
    Ig Fraction
    Top Product
    Discover our top product CHRNB4 Primärantikörper
  • Applikationshinweise
    WB: 1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Haltbarkeit
    6 months
  • Zhang, Kranzler, Poling, Gelernter: "Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility." in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Vol. 35, Issue 11, pp. 2211-24, (2010) (PubMed).

    Amos, Gorlov, Dong, Wu, Zhang, Lu, Scheet, Greisinger, Mills, Spitz: "Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study." in: Journal of the National Cancer Institute, Vol. 102, Issue 15, pp. 1199-205, (2010) (PubMed).

    Saccone, Schwantes-An, Wang, Grucza, Breslau, Hatsukami, Johnson, Rice, Goate, Bierut: "Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans." in: Genes, brain, and behavior, Vol. 9, Issue 7, pp. 741-50, (2010) (PubMed).

    Hansen, Xiao, Rice, Bracci, Wrensch, Sison, Chang, Smirnov, Patoka, Seldin, Quesenberry, Kelsey, Wiencke: "Fine mapping of chromosome 15q25.1 lung cancer susceptibility in African-Americans." in: Human molecular genetics, Vol. 19, Issue 18, pp. 3652-61, (2010) (PubMed).

  • Target
    CHRNB4 (Cholinergic Receptor, Nicotinic, beta 4 (Neuronal) (CHRNB4))
    Andere Bezeichnung
    CHRNB4 (CHRNB4 Produkte)
    Synonyme
    Acrb-4 antikoerper, Acrb4 antikoerper, cholinergic receptor nicotinic beta 4 subunit antikoerper, cholinergic receptor, nicotinic, beta polypeptide 4 antikoerper, CHRNB4 antikoerper, Chrnb4 antikoerper
    Hintergrund
    After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
    Molekulargewicht
    56380
    NCBI Accession
    NP_000741, NP_001243496
    UniProt
    P30926
Sie sind hier:
Kundenservice